SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068565
Filing Date
2024-08-14
Accepted
2024-08-14 07:05:53
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210672-10q_unicycive.htm   iXBRL 10-Q 941051
2 MANUFACTURING AND SUPPLY AGREEMENT DATED AS OF OCTOBER 31, 2020 BY AND BETWEEN U ea021067201ex10-1_unicycive.htm EX-10.1 95003
3 FIRST AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT DATED JUNE 25, 2024 BY AND ea021067201ex10-2_unicycive.htm EX-10.2 41265
4 EMPLOYMENT AGREEMENT (THIS "AGREEMENT"), DATED AUGUST 12, 2024, BY AND AMONG UNI ea021067201ex10-3_unicycive.htm EX-10.3 133230
5 CERTIFICATION ea021067201ex31-1_unicycive.htm EX-31.1 11220
6 CERTIFICATION ea021067201ex31-2_unicycive.htm EX-31.2 11199
7 CERTIFICATION ea021067201ex32-1_unicycive.htm EX-32.1 3724
8 CERTIFICATION ea021067201ex32-2_unicycive.htm EX-32.2 3684
  Complete submission text file 0001213900-24-068565.txt   6822124

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE uncy-20240630.xsd EX-101.SCH 65227
10 XBRL CALCULATION FILE uncy-20240630_cal.xml EX-101.CAL 34065
11 XBRL DEFINITION FILE uncy-20240630_def.xml EX-101.DEF 334979
12 XBRL LABEL FILE uncy-20240630_lab.xml EX-101.LAB 585495
13 XBRL PRESENTATION FILE uncy-20240630_pre.xml EX-101.PRE 339130
81 EXTRACTED XBRL INSTANCE DOCUMENT ea0210672-10q_unicycive_htm.xml XML 806761
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40582 | Film No.: 241204107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)